Literature DB >> 657150

Qualitative and quantitative toxicity of single and sequential sublethal doses of 5-fluorouracil in BDF mice.

S D Harrison, E P Denine, J C Peckham.   

Abstract

Qualitative and quantitative toxicity studies were conducted in BDF mice after ip injection of 33, 66, 134, and 200 mg/kg of 5-fluorouracil (5-FU) in daily doses for 1, 2, 3, or 4 consecutive days. Groups of five mice from each schedule and dose level provided blood and selected visceral organs for hematologic and histologic evaluation on posttreatment Days 1, 3, 6, 10, 14, and 21. Comparable groups of five mice were blood donors for biochemical evaluation of pooled plasma samples. The results indicated the onset, severity, and duration of injury to target organs and characterized the relationship of sublethal toxicity to drug dose and frequency of administration. Marrow suppression was reflected in peripheral erythropenia, thrombocytopenia, and leukopenia and also in medullary erythropenia and granulocytopenia. A transient elevation of plasma LDH, loss of body weight, and appearance of microscopic lesions of the gastrointestinal mucosae were additional indices of toxicity. The BDF mouse appears to provide a good qualitative and quantitative prediction of 5-FU toxicity, although the mouse apparently is quantitatively more sensitive than man.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 657150

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  7 in total

1.  Hematologic and histopathologic evaluation of N-(phosphonacetyl)-L-aspartate (PALA) in mice.

Authors:  S D Harrison; H D Giles; E P Denine
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

2.  Antitumor drug toxicity in tumor-free and tumor-bearing mice.

Authors:  S D Harrison; H D Giles; E P Denine
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

Review 3.  Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: the role of inflammation.

Authors:  Chun Seng Lee; Elizabeth J Ryan; Glen A Doherty
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

4.  Chlorozotocin, an anti-tumour agent lacking bone marrow toxicity at therapeutic doses: effects on lymphocyte subpopulations in mice.

Authors:  R I Fisher; G L Mandell; F Bostick; M G McMenamin; T Anderson
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

5.  Recovery of humoral and cellular immunity by soluble mediators after 5-fluorouracil-induced immunosuppression.

Authors:  V J Merluzzi; K Last-Barney; B M Susskind; R B Faanes
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

6.  Biochemical consequences of 5-fluorouracil gastrointestinal toxicity in rats; effect of high-dose uridine.

Authors:  J Kralovanszky; N Prajda; S Kerpel-Fronius; T Bagrij; E Kiss; G J Peters
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

7.  Evaluation of plasma 5-fluorouracil nucleoside levels in patients with metastatic breast cancer: relationships with toxicities.

Authors:  M Barberi-Heyob; B Weber; J L Merlin; C Dittrich; E A de Bruijn; E Luporsi; F Guillemin
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.